(VIANEWS) – The NASDAQ ended the session with Pacific Biosciences of California (PACB) rising 5.75% to $4.88 on Wednesday while NASDAQ fell 0.15% to $11,053.08.

Volume

Today’s last reported volume for Pacific Biosciences of California is 5853620, 18.33% below its average volume of 7168130.

Pacific Biosciences of California’s last close was $4.61, 87.32% under its 52-week high of $36.36.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 17% for the ongoing quarter and 30.3% for the next. The company’s growth estimates for the current quarter and the next is a negative 57.1% and a negative 500%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be oversold (<=20).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $4.88 at 18:26 EST, way under its 52-week high of $36.36 and way above its 52-week low of $4.16.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way under its 50-day moving average of $6.51 and way under its 200-day moving average of $16.44.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here